Activity of clinafloxacin, trovafloxacin, quinupristin/dalfopristin, and other antimicrobial agents versus Staphylococcus aureus isolates with reduced susceptibility to vancomycin
Ma. Cohen et Md. Huband, Activity of clinafloxacin, trovafloxacin, quinupristin/dalfopristin, and other antimicrobial agents versus Staphylococcus aureus isolates with reduced susceptibility to vancomycin, DIAG MICR I, 33(1), 1999, pp. 43-46
Isolations of Staphylococcus aureus strains with reduced susceptibility to
vancomycin are now being reported worldwide. In testing here by broth micro
dilution according to NCCLS guidelines and applying vancomycin breakpoint c
riteria (susceptible at 4 mu g/mL), two of three strains were susceptible (
MICs at 4 mu g/mL) rather than intermediate (MICs at 8 mu g/mL) as previous
ly reported by other laboratories. Clinafloxacin was more active (MICs/MBCs
at 0.5 to 2 mu g/mL) than ciprofloxacin, grepafloxacin, levofloxacin, oflo
xacin, and sparfloxacin. Trovafloxacin, trimethoprim/sulfamethoxazole, and
quinupristin/dalfopristin were the next most active agents, although quinup
ristin/dalfopristin was bactericidal against only two of these three strain
s. Amikacin, imipenem, oxacillin, and rifampin were less active. (C) 1999 E
lsevier Science Inc.